9 results
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... for First Time Pulmonary ... #PE #Pulmonary # ... #Algorithm #management ... #hematology #VTE
Diffuse large B cell lymphoma (DLBCL) - Management and Treatment Algorithm

By Matthew Ho, MD PhD @MatthewHoMD

#Diffuse
lymphoma (DLBCL) - Management ... and Treatment Algorithm ... Diffuse #large #Bcell ... #Treatment #Algorithm ... #oncology #hematology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
for the treatment ... vein thrombosis; PE ... = pulmonary embolism ... Anticoagulation #Management ... #Hematology #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... incidental DVT or PE ... single subsegmental PE ... Anticoagulation #Management ... #Hematology #Oncology
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Pulmonary Thromboendarterectomy
Chronic Thromboembolic Pulmonary Hypertension
Definition: mean pulmonary-artery pressure > 25mmHg
Hypertension (CTEPH ... 6 months after PE ... Bypass Other Treatment ... and recurrent VTE ... Thromboendarterectomy #diagnosis #management
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
• Induce blast cell ... Imaging: CXR- pulmonary ... Infection (sepsis), PE ... APML #diagnosis #management ... #hematology #oncology
Hepatopulmonary Syndrome - Diagnosis and Management Summary
A defect in arterial oxygenation due to a gas exchange
disease - Portal hypertension ... cirrhosis • Intra-pulmonary ... contrast-enhanced TTE ... ) on room air Treatment ... #treatment #hepatology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Algorithm Treat ... proximal DVT or PE ... therapy - Second VTE ... #Algorithm #management ... #hematology #anticoagulation
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
effusion, INC risk PE ... , Pulmonary amyloidosis ... Nephrogenic DI Hematologic ... Adenocarcinoma Treatment ... #Diagnosis #Management